Autonomous Interventions and Robotics (AIR) Program

Autonomous Interventions and Robotics (AIR) Program is sponsored by Advanced Research Projects Agency for Health (ARPA-H). The AIR program aims to develop robots capable of performing parts or all of surgical interventions autonomously.

AIR Teaming Profiles | ARPA-H This page is designed to help facilitate connections between prospective proposers, which ARPA-H anticipates will be necessary to achieve the goals of the Autonomous Interventions and Robotics ( AIR ) program. Prospective performers are encouraged (but not required) to form teams with varied technical expertise to submit a proposal.

If either you or your organization are interested in teaming, please create a profile via the ARPA-H Solutions Portal linked below. Your details will then be added to this page, which is publicly available. Please note that by publishing the teaming profiles list, ARPA-H is not endorsing, sponsoring, or otherwise evaluating the qualifications of the individuals or organizations included here.

Submissions to the teaming profiles list are reviewed and updated periodically. To narrow the results in the Teaming Profiles List, please use the input below to filter results based on your search term. The list will filter as you type.

June Lee, MD, PhD NSMS Dr.JuneLee@nsmsusa. org Bethesda, MD Since our founding on March 22, 1996, the National Society of Medical Scientists (NSMS) has been dedicated to defining the future of healthcare science, technology, and development in the United States.

Our members are clinicians (Neurosurgeons, Interventional Radiologists) with deep expertise in defining clinical requirements, designing prospective clinical trials, establishing safety protocols, and validating autonomous medical devices, including AI-driven systems. Focus on robotics/microbots.

We seek partners with strong capabilities in Robotics Engineering (for TA1 actuation/navigation), Control Systems, Algorithm Development (for autonomous decision-making under uncertainty/UQ), and Microbot Fabrication/Propulsion (for TA2). We offer clinical expertise, access to realistic phantom/cadaver labs, and a pathway to FDA-compliant trial design. TA2: Microbots, TA1: Endovascular Robotics Andinet Enquobahrie Kitware andinet.

enqu@kitware. com Carrboro, NC Kitware advances surgical simulation through integrated platforms that combine imaging, visualization, simulation, and physiological modeling using our open-source tools (VTK/ITK/3D Slicer/Pulse/ParaView). We build custom virtual training environments featuring validated cardiovascular physiology, haptic-enabled device mechanics, and advanced X-ray fluoroscopic image generation solutions.

Kitware has experience both as a performer on large DARPA and ARPA-H programs. (1) Robotics partner for co-development and validation, (2) High volume stroke center with neurovascular datasets and endovascular procedure expertise, and (3) Real-time tool-tissue interactions and real-time fluid simulations. TA1: Endovascular Robotics Hongsoo Choi University of Massachusetts Amherst hongsoochoi@umass.

edu Amherst, MA I develop magnetically controlled microrobotic guidewires, catheters, and electromagnetic/VR-enabled control systems that provide precise, real-time navigation for neuro- and cardiovascular interventions.

With over 10 years of innovation and extensive in vivo validation in swine, my work actively advances steerable microrobots that can serve as the foundation for autonomous thrombectomy and next-generation microbotic interventions, expanding access to life-saving care. We seek partners with expertise in regulatory strategy, commercialization, and advanced imaging (C-arm, biplane, fluoroscopy).

We also need stroke specialists and hospitals capable of swine studies and willing to install our microrobotic systems, plus surgical navigation and AI experts to enhance autonomous microrobot guidance for future human translation. TA1: Endovascular Robotics, TA2: Microbots Jung-eun Park XCath jungeun. park@xcath.

com Huston, TX XCath is advancing neurovascular intervention robotics by developing a highly precise, stable, and responsive robotic platform designed for navigating complex cerebral vasculature.

Current research focuses on improving robotic manipulation, haptic safety mechanisms, real-time procedural visualization, and seamless integration with clinical imaging systems to enhance accuracy, consistency, and overall procedural performance. We seek TA1-B partners who can build a high-fidelity endovascular simulation and imaging resource for our neurovascular intervention robot.

Ideal partners develop in silico vascular and clot models, realistic fluoroscopy simulators, and large CTA/fluoro datasets, and can integrate their virtual testbed with our robotic platform and FDA-aligned validation workflows. TA1: Endovascular Robotics Igor Aronson Pennsylvania State University isa12@psu. edu University Park, PA We are developing microscopic robots powered by enzymatic reactions.

The autonomous robots can deliver a payload (e.g., a drug) into the desired location оr report a chemical of interest (e.g., a contaminant or signaling molecule). Fabricating enzyme-propelled and acoustically/magnetically propelled microrobots for cargo delivery. We are looking for partners with expertise in particle synthesis and enzyme-mediated functionalization.

Possible technologies include 3D nanoprinting and additive manufacturing. Experience in medical applications. TA2: Microbots, TA1: Endovascular Robotics John Sadowski Planned Systems International Jsadowski@atlintl.

com Washington, DC We are a global health IT solutions provider with a track record in both ARPA-H execution and clinical integration. PSI specializes in predictive modeling using AI, and has 5 patents on robotic autonomous healthcare. We own a lightweight electronic health record system utilized by the federal government, and have existing contracts with the U.S. Defense Health Agency and the VA.

PSI has already won ARPA-H contracts, which can significantly de-risk aspects of potential partners' solutions. We are seeking to partner with organizations that have the expertise for the technical robotics and bioscience aspects of the program. TA2: Microbots, TA1: Endovascular Robotics Deepak Raina Indian Institute of Technology Mandi deepakraina@iitmandi.

ac. in Mandi We focus on developing autonomous robotic systems for trauma procedures such as ultrasound-guided REBOA and central venous catheterization (CVC). Our research develops intelligent image-guided perception, control, and motion-planning algorithms to enable safe, precise, and end-to-end automation of these clinical interventions.

We seek teaming partners with expertise in soft robotics, medical robot mechanism design, ultrasound imaging analysis, Deep learning for perception and clinical translation. TA1: Endovascular Robotics Nicholas Marion SRI International nicholas. marion@sri.

com Menlo Park, CA SRI International’s robotics lab specializes in designing novel robotic hardware and software solutions. SRI has experience building novel surgical robot platforms such as the Taurus-M, but also with robotic simulation and system integration (as demonstrated in DARPA Trauma Pod).

SRI maintains a machine shop and fabrication facilities along with a mechanical and software team for rapid prototyping and development of new technologies. SRI is searching for partners with novel sensing and modeling technology as well as partners with existing or nearly ready intervention approaches. TA1: Endovascular Robotics, TA2: Microbots nitesh katta Baylor college of medicine nitesh.

katta@bcm. edu Houston, TX Nanobiophotonics Robotics for AIR program TA1: Endovascular Robotics, TA2: Microbots Steven Steinway Brigham and Women's Hospital/Harvard Medical School ssteinway@bwh. harvard.

edu Boston, MA gastroenterology/interventional endoscopy engineering collab TA2: Microbots Zhenhua Tian Virginia Tech tianz@vt. edu Blacksburg, VA Our lab works on microrobots controlled by ultrasound. We have published several papers about using ultrasound to move microrobots in vascular structures.

Meanwhile, we are experienced with ultrasound imaging to monitor the locations of microrobots. We need biomedical collaborators who can identify the potential applications and apply our technology for animal or clinical demonstrations. TA2: Microbots Naresh Menon ChromoLogic nmenon@chromologic.

com Monrovia, CA We are pioneering bio-inspired neuromorphic computing algorithms capable of global path optimization by solving the Hamiloto-Jacobi-Bellman optimal control equation in milliseconds. Currently being applied to autonomous vehicles for rapid obstacle avoidance, it is ideally suited for robotic surgery.

Furthermore, we have 18+ years of medical image processing domain expertise that our team of scientists and clinicians have used in developing medial applications (FDA, pre-clinical, clinical). Robotic companies with whom we can integrate our neuromorphic edge controllers based on our image guidance expertise. Our software layer is hardware and firmware agnostic.

TA1: Endovascular Robotics, TA2: Microbots Swetadri Vasan Setlur Nagesh University at Buffalo Neurosurgery swetadri. vasan@gmail. com Buffalo, NY Our research aims to develop autonomous engines to drive endovascular robots for stroke intervention.

We integrate novel imaging and training methods, including reinforcement learning with human feedback, to achieve robust system training and validation across in vitro and in vivo models.

We seek to collaborate with partners developing robotic technology for catheter navigation, as well as simulation environment that enable autonomous systems to practice and refine their skills TA1: Endovascular Robotics, TA2: Microbots VERONIKA MAGDANZ University of Waterloo veronika. magdanz@uwaterloo.

ca Waterloo, Ontario, Canada microrobotics, wireless magnetic small scale robots for noninvasive surgery, cell and drug delivery, applications such as blood clot removal, kidney and gallstone removal clinicians TA2: Microbots, TA1: Endovascular Robotics Brian Yanoff GE Healthcare Technology and Innovation Center yanoff@gehealthcare. com Niskayuna, NY We conduct research and development on many aspects of medical imaging.

We have extensive expertise and experience in X-ray, CT and MR vascular imaging systems. We develop advanced 3D reconstruction and other algorithms for all modalities, and machine learning addressing a wide range of clinical needs. We have experience developing state-of-the-art clinical prototypes for commercial and research projects.

We also have strong capabilities in modeling and simulation of imaging systems We are open to collaborating with a robotics team within the TA1-A program area.

Our team offers expertise in: Integration with the control system and imaging chain of GE Healthcare C-arm systems; Modeling and simulation of imaging systems, including image analysis, surgical planning, and simulation using pre-operative CT, cone-beam CT, and MR datasets; Development of advanced navigation methods and algorithms. TA1: Endovascular Robotics Dani Kiyasseh Halsted AI dani@halstedhealth.

ai Sunnyvale, CA, USA, CA Unlocking the value of surgical videos with state-of-the-art foundation models Hardware in which we can deploy our software TA1: Endovascular Robotics Mark Palmer Synopsys, Inc mark. palmer@ansys. com Sunnyvale, CA Synopsys including Ansys part of Synopsys has over 50 years of experience in providing technologies and platforms for engineering simulation and AI.

We are a trusted partner across all major industry sectors in delivering “silicon to systems” solutions that make world-changing innovations possible. Our solutions and platforms enable engineering teams to tackle increasing complexity, cost, and time-to-market pressure in developing silicon-powered, software-defined and AI-enhanced products. We seek partners committed to accelerating their product lifecycle.

For hardware we enable generative AI design and System-on-a-Chip hardware and software validation prior to manufacturing. Partners will also seek synthetic data generation based on ASME VV40/FDA Model Credibility guidances leveraging FDA approved clinical image processing coupled to full multiphysics ecosystem including tissue mechanics, optics, and FSI for training AI on navigation and device-tissue interaction.

TA1: Endovascular Robotics, TA2: Microbots Katie Anderson K2A2 Consulting k2a2consulting@gmail. com Chattanooga, TN User experience design of surgical robots. My organization has connections across the field of UX including but not limited to regulatory, pre-clinical research, study design, human factors, user need and requirement development, and clinical engineering expertise.

TA2: Microbots, TA1: Endovascular Robotics Sophie Beckman Cimit sbeckman3@mgh. harvard. edu Boston, MA Cimit is a leader in health innovation with 25+ years of experience advancing groundbreaking solutions to complex health challenges.

We use our hands-on approach, proven process, custom tools and global experts to accelerate innovative ideas toward commercialization. Cimit currently leads the NIH Blueprint MedTech program and has specific expertise in evaluating, derisking, accelerating, and deploying targeted solutions for nervous system disorders, including surgical interventions for stroke.

Cimit seeks collaborative partners that will benefit from complex project management, data integration, engineering, product-market fit, regulatory, and commercialization support. We offer expertise in early-stage evaluation, derisking, innovation and solicitation management, and consortium coordination.

Partners can leverage our tailored infrastructure, tools, resources, expert network, and streamlined methodologies to advance their integrated surgical intervention solutions. TA1: Endovascular Robotics, TA2: Microbots Yasemin Ozkan-Aydin University of Notre Dame yozkanay@nd. edu NOTRE DAME, IN Our lab focuses on the development of bioinspired robotic platforms optimized for a Low Reynolds number environment.

While our current experimental systems are designed at the centimeter scale, the insights gained from our research in fluid-structure interactions and non-standard control systems are directly applicable to the locomotion and navigation requirements of TA2. We offer extensive expertise in robotic design, embedded control architectures, and the creation of experimental platforms.

We specifically seek clinical partners to guide the selection of these indications and microrobotics experts to assist in the miniaturization of power supplies and computational processing. TA2: Microbots Eric Claude MPR Associates eclaude@mpr.

com Alexandria, VA MPR's Health and Life Science Team provides services for design, development, engineering, and testing for medical devices, diagnostic instruments, and pharma/biopharma manufacturing. We use risk-based approaches to develop bespoke processes, devices, and test equipment to ensure safety, reliability, and regulatory compliance.

With our team of 250 engineers, designers, and scientists, MPR’s expertise supports translation of innovations from lab to commercial production.

MPR seeks to partner with prime performers who wish to leverage our capabilities to reduce risk and accelerate development through: technology evaluation, solution definition, rapid development for bench-top feasibility and risk reduction, design and development of commercial-ready devices, testing/validation, and preparation of FDA-required documentation.

TA1: Endovascular Robotics, TA2: Microbots Thurman Peterson Vetforce Solutions LLC Thurman. peterson@vetforcesolutions. com Orlando, FL VetForce Solutions focuses on clinical research data management and infrastructure that enables secure, compliant, and reusable handling of health research data.

Our work centers on EDC and eTMF operations, data ingestion and validation, regulatory-ready datasets, and scalable data pipelines that support analytics, AI readiness, and cross-program reuse within federally funded biomedical research environments.

VetForce Solutions seeks teaming partners that complement our clinical data management focus, including secure cloud infrastructure providers, interoperability and data standards experts, analytics and AI developers, and research performers. We value partners experienced with OTA execution, reusable infrastructure, and federally funded research who prioritize compliance, agility, and shared delivery of AIR mission outcomes.

TA1: Endovascular Robotics, TA2: Microbots Mohsen Annabestani Weill Cornell Medicine annabestany@gmail. com New York, NY Our research focuses on AI-enabled medical devices for minimally invasive interventions.

We integrate diverse soft robotic systems, including silicone-based, 3D-printed, cable-driven, and ionic platforms, with embedded sensing, advanced machine and deep learning, medical imaging, and extended reality technologies to develop intelligent, safe, and scalable solutions for medical procedures, wearable biosensing, and image-guided clinical interventions.

We are primarily seeking teaming partners with expertise in endovascular neurosurgery or neurointerventional radiology, particularly in mechanical thrombectomy workflow, device use, and clinical validation. We also welcome collaborators in autonomous robotic control, AI-guided navigation, and medical imaging who are motivated to translate soft robotic systems into safe, deployable stroke interventions.

TA1: Endovascular Robotics Ryan DeBoer The Shape Sensing Company ryan. deboer@shapesensing. com Austin, TX The Shape Sensing Company (TSSC) develops fiber optic sensing that provides continuous, real-time measurement of the full 3D shape and pose of endovascular guidewires and catheters.

Our focus is enabling closed-loop control and safety for autonomous and semi-autonomous robotic systems by delivering accurate, low-latency tool state along the entire device length, without dependence on fluoroscopic tracking and immune to electromagnetic interference.

We seek TA1-A endovascular robotics teams developing autonomous or semi-autonomous catheter and guidewire platforms that require continuous tool state for control and safety. As a subcontractor, we provide full-length shape sensing to support closed-loop navigation, safety monitoring, and repeatable system performance without reliance on tip-only tracking or external field generators.

TA1: Endovascular Robotics Sameer Peesapati Synthesize sameer@synthesize. health Toronto Canada We are a team of 3 (MD (25+ years as an interventional cardiologist), Roboticist with HF/Quality/Reg/Risk/ML expertise (15 years of exp), ML Scientist in Medical Imaging (10 years of exp)), who hop on as a Sub-contractor.

We have hands-on experience in image-guided interventional devices, Minimally invasive surgical devices, and ML algorithms on Imaging: - Clinical areas: Commercialized in HOPD and ASCs in Cardiology, GI and Urology, Spine and Neuro Looking to partner with TA1 and TA2 teams as a sub-contractor offering - - Imaging ML algorithm development - HFE Research and Validation (HE75, IEC 62366-1/2, ISO 9241) - Design Risk Assessment (ISO 14971) - Clinical Study Design (ICH E6 ISO 14155) - FDA Regulatory Pre-sub and Filing - QMS set up in accordance with new QMSR (ISO 13485) TA1: Endovascular Robotics, TA2: Microbots Cagatay M.

Oral ETH Zurich oralca@ethz. ch Zurich Electromagnetic navigation systems and magnetic microrobots Clinical expertise, real-time imaging TA2: Microbots, TA1: Endovascular Robotics Margaret McGuinness University of Notre Dame mmcguinness@nd. edu South Bend, IN We are developing centimeter-scale shape-changing soft mobile robots capable of navigating the pathways inside the human intestines.

Our current focus areas are in mechanical design, modeling, and low-level control of these robots. We are looking for technical collaborators focused on other aspects of system design, as well as clinical partners to help inform and implement translation of our technology. TA2: Microbots, TA1: Endovascular Robotics Thomas Hayes Ursus Medical Designs LLC thayes@ursus-medical.

com Pittsburgh, PA Developing next generation ASIC based ultrasound imaging platform, optimized for AI, dramatically greater imaging quality, small footprint, power consumption and cost. System allows autonomous scanning and continuous monitoring.

System is designed to add superior imaging capabilities and integrate with robotics systems, surgical robots etc. Ultrasound transducer configurations are flexible, can be configured to optimize any application. Surgical Robotics teams looking for superior imaging, System provides images and/or raw ultrasound data for AI analysis. TA1: Endovascular Robotics, TA2: Microbots Mark Fingerle Ramina Brainlab SE mark.

fingerle@brainlab. com Munich, Germany Brainlab develops software-first platforms for image-guided therapy: patient-specific 3D modeling (CT/MR/US), intraoperative imaging, navigation and device tracking, advanced visualization, workflow/data platforms, and integration with robotic suites.

Current focus in endovascular: 3D navigation independent of fluoroscopy, digital-twin guidance, and automation of key procedural steps to reduce radiation/contrast and improve efficiency.

Seeking teaming partners for autonomous endovascular interventions: robotic catheter/guidewire actuation and control, sensorized devices (EM/FORS/US), autonomy/AI for perception-planning-control with safety assurance, simulation/bench models and datasets, clinical sites for validation (aortic/neuro/peripheral), and regulatory/quality support for a pathway to clinical translation.

TA1: Endovascular Robotics, TA2: Microbots Mehdi Tarrit Mirakhorli Hawksbill mehdi. mirakhorli@hawksbill. ai Honolulu, HI Agentic AI, Fail-Safe & Regulatory Pathways Our expertise is in Agentic AI, simulations, failure modes, assurances and fail-safe mechanisms.

We are looking to partner as a sub. We have prior experience working with ARPA-H, DARPA and other agencies. TA1: Endovascular Robotics, TA2: Microbots Sabino Zani DUMC sabino.

zani@duke. edu Durham, NC Telerobotics, steerable catheters, autonomous platforms. Collaboration and synergy.

TA1: Endovascular Robotics, TA2: Microbots Danielle Walker MedAcuity dwalker@medacuity.

com Westford, MA MedAcuity brings deep, hands-on experience designing and developing multiple remote therapy systems for endovascular robotics supporting cardiovascular and neurovascular intervention, helping companies safely extend control from the physician console to the patient-side robot via telesurgery without compromising performance or compliance.

The ideal teaming partner for this effort brings a mature medical robotic platform with strong clinical relevance and autonomy IP, along with access to interventional expertise and real-world deployment pathways, enabling MedAcuity to focus on delivering trusted, safety-critical software, verification, and regulatory-ready system integration. TA1: Endovascular Robotics Changyong Cao Case Western Reserve University ccao@case.

edu Cleveland, OH soft robotics and soft electronics instustry partners or research institutions TA1: Endovascular Robotics Larry Bartolotti CGI larry. bartolotti@cgifederal. com Fairfax, VA CGI Federal brings advanced modeling/simulation, cloud infrastructure, AI for medical imaging and navigation, and systems engineering for complex robotic platforms.

We deliver data engineering, cybersecurity, IV&V, and CUI compliant environments, plus regulatory systems, FDA aligned validation, PMO, and ARPA style program management to help AIR teams transition concepts into regulated clinical use. CGI Federal is looking to support a prime with deep expertise in endovascular robotic systems, autonomous interventional workflows, and medical microbot design, fabrication, and testing.

We seek partners who lead on benchtop/phantom, cadaver, and animal studies, as well as clinical translation and FDA strategy, while leveraging CGI for secure data, integration, and program management support. TA1: Endovascular Robotics Fredrick Joseph SurgeonsLab Inc. fredrick. joseph@surgeonslab.

com Dallas, TX SurgeonsLab focuses on high-fidelity physical and virtual simulation for interventional radiology and neurovascular procedures. Core work includes rapid DICOM-to-3D/4D patient-specific vascular models with physiologic flow, hybrid physical-digital endovascular simulation, and ground-truth validation for robotic and autonomous systems.

SurgeonsLab is an approved simulation partner for leading endovascular device manufacturers, enabling realistic, device-compatible validation and translation. SurgeonsLab seeks teaming partners developing endovascular robotic platforms, autonomous navigation and AI control, micro- or milli-scale intervention devices, advanced sensing (shape, force, imaging), and clinical validation pipelines.

Ideal partners require patient-specific, flow-enabled physical and virtual simulation to train, validate, and benchmark autonomous or microbot-based interventions, and share a focus on safe translation of thrombectomy and interventional radiology procedures. TA1: Endovascular Robotics, TA2: Microbots Sameer Sonkusale Tufts University sameer. sonkusale@tufts.

edu Boston, MA Relevant expertise: Miniaturized chemical/biological sensors to guide catheters or microbots, Controlled delivery of cargo such as embolic agents or drugs, Micro and nanofabrication, Device fabrication, Control and communication. Miniaturized pressure flow and temperture sensors, Implantable chemical and biosensors, Power Considerations; Integrated Circuits and Instrumentation.

for TA1 - Catheter/Guidewire, fluoroscopy, clinical collaborator. For TA2 - motion, planning, mechatronics aspects for biopsy or ablation, clinical collaborator Robotics; Clinical Expertise; TA2: Microbots, TA1: Endovascular Robotics Jithesh Veetil Medical Device Innovation Consortium (MDIC) jveetil@mdic.

org Arlington, VA We operate as a public-private partnership that accelerates the development and access to medical technologies by bringing together industry, the FDA, and patient groups. MDIC focuses on improving regulatory science, manufacturing quality, and incorporating patient preferences through initiatives like the "Case for Quality", "Patient-Centered Benefit-Risk Assessment" and such programs.

Broader coalition in the MedTech ecosystem to make greater impact. TA1: Endovascular Robotics, TA2: Microbots Ryan Sochol University of Maryland, College Park rsochol@umd. edu College Park, MD Building steerable, fluidically actuated soft robotic microcatheters and guidewires via two-photon 3D micro/nanoprinting.

Teams that could leverage the 3D micro/nanoprinting and/or soft robotic surgical tools strategy. TA1: Endovascular Robotics, TA2: Microbots Michael Yip UC San Diego yip@ucsd.

edu San Diego, CA Experts in endovascular robotics, robot hardware design, and surgical robot autonomy Imaging Technology and Digital Twinning Partners, Clinical Scientists, Military Medicine TA1: Endovascular Robotics Abigail Cember Rhino Federated Computing abby@rhinofcp.

com Boston, MA Rhino's federated computing platform allows for model training while keeping source data private; for example, models for medical robotics which must be trained on a great number of data sets arising from real human patients. We are interested in demonstrating (and improving, if need be) our platform's capability to facilitate this use case of federated learning.

We do not have a preference for focusing on either microbots or endovascular robotics. We seek to join a team of roboticists, clinicians and others, to whom we can provide the data and computational infrastructure enabling the secure training of embodied AI models on real-world data subject to rigorous privacy constraints. TA2: Microbots, TA1: Endovascular Robotics Sung Kwon Cho University of Pittsburgh skcho@pitt.

edu Pittsburgh, PA developing a microrobotic powered guidewire Medical doctors who can guide and explore direct applications of our developing system TA1: Endovascular Robotics, TA2: Microbots Youngjae Chun University of Pittsburgh yjchun@pitt. edu Pittsburgh, PA Our organization advances surgical interventions and medical devices to expand access to life-saving care.

Key areas include stroke treatment via thrombectomy, minimally invasive procedures, and small-scale AIR robot development. By integrating engineering, clinical expertise, and industry collaboration, we deliver safer, more efficient, and widely accessible healthcare solutions. Our organization seeks teaming partners with expertise in medical device development, robotics, artificial intelligence, clinical care, and engineering innovation.

Ideal partners bring complementary skills, share a commitment to advancing autonomous and minimally invasive surgical solutions, and are ready to collaborate on high-impact, translational projects that improve patient outcomes and expand access to life-saving procedures. TA1: Endovascular Robotics, TA2: Microbots Xiaoguang Dong Vanderbilt University xgdong2013@gmail.

com Nashville, TN Magnetic soft microrobot for drug delivery Medical imaging partners TA2: Microbots, TA1: Endovascular Robotics Allison Okamura Stanford University aokamura@stanford. edu Stanford, CA Design and control of novel robots, learning from demonstration (including teleoperation and haptic feedback) Autonomy expertise, clinical expertise TA1: Endovascular Robotics, TA2: Microbots Glenn Block Synap Biotech inc. glenn.

block@synapbio. com Norfolk, VA Synap Biotech Inc. is a Virginia-based company developing first-in-class Intranasal Nanobody® therapies to restore the brain’s ability to repair itself after stroke, TBI, and neurodegenerative disease. Our lead program targets Nogo-A, a key blocker of neuroplasticity, using non-invasive intranasal delivery to bypass the blood–brain barrier and enable true brain repair.

Enhancing Outcomes After Autonomous Thrombectomy AIR expands access to curative thrombectomy, but restoring lost brain function still requires neuroregeneration.

Synap’s Intranasal Nanobody® therapy: Promotes neuroplasticity after ischemic injury Can be administered immediately post-procedure Fits in any clinical setting (ER, stroke unit, rural hospital) Pairs perfectly with a minimally invasive intervention model APR handles the clot; Synap handles the recovery. TA1: Endovascular Robotics, TA2: Microbots Jayne Dadmun The University of Tennessee, Knoxville jdadmun@utk.

edu Knoxville, TN Health innovation, research and education with flagship programs in cancer research, surgical robotics, substance abuse and data analytics. Multi-institutional approach to enhance applications of process optimization, signal prcoessing, and robotics in surgery TA1: Endovascular Robotics, TA2: Microbots Juan Wachs Purdue University jpwachs@purdue.

edu West Lafayette, IN telerobotics, autonomous robots, life saving skills, AI medics dual robotic platforms TA1: Endovascular Robotics, TA1: Endovascular Robotics Fei Liu University of Tennessee, Knoxville fliu33@utk. edu Knoxville, TN, US, TN Our research focuses on advancing surgical robotics through physics-based modeling, embodied AI, and intelligent control.

We develop computational representations of tool–tissue interaction, generative simulation frameworks, and data-driven policies that enable safer and more capable robot-assisted procedures. Our work integrates 3D vision, differentiable simulation, and learning-based control to build real-time digital twins and intraoperative assistance systems.

surgical robotics company who is working on endovascular robots TA1: Endovascular Robotics, TA2: Microbots Jindong Tan University Of Tennessee, Knoxville tan@utk. edu Knoxville, TN The University of Tennessee specializes in microbots and minimally invasive interventions.

We develop autonomous and semi-autonomous robotic navigation, AI-guided control, soft and magnetic actuation, real-time imaging, and digital-twin platforms to enable precise, adaptive, and safer intravascular procedures for stroke, cancer, and cardiovascular disease.

We seek partners with complementary capabilities, rapid prototyping, regulatory experience, and pathways to real-world deployment in stroke, oncology, and cardiovascular care. TA2: Microbots, TA1: Endovascular Robotics Payam Eliahoo Radioson Corporation peliahoo@radiosoninc. com Los Angeles, CA Robotic surgery clinicians TA1: Endovascular Robotics, TA2: Microbots Wei Gao California Institute of Technology weigao@caltech.

edu Pasadena, CA, CA The Gao Lab is working on the design of microrobots powered by bioavailable fuels or externally applied fields such as ultrasound and magnetic fields. These systems enable a range of sophisticated capabilities, including biosensing, targeted drug delivery, precision surgery, bioimaging, and cellular isolation.

Clinical partners for evaluation of the micro/nanorobotics; experts with advanced remote imaging and control expertise. TA2: Microbots HAN-PANG CHIU SRI International han-pang. chiu@sri.

com Princeton, NJ SRI Center for Vision Technologies has a long history in autonomous navigation with small mobile platforms and devices. Recently, we have created novel technologies to ground foundation models for generating navigation plans and medical procedure guidance under multiple government programs.

We also have state-of-the-art data augmentation and generative AI techniques which can be used to increase realism and variation in the training data and simulation. We are looking for medical partners, with expertise in the medical devices and procedures related to TA1. TA1: Endovascular Robotics, TA2: Microbots Jundong Li University of Virginia jundong@virginia.

edu Charlottesville, VA Our work spans from foundational algorithm design to practical predictive models that integrate complex structured data and real-world signals, and we have deep expertise in building scalable and reliable AI models suitable for resource-constrained environments.

We seek to join a multidisciplinary team that would benefit from advanced AI and computational modeling expertise, particularly in areas such as multimodal model development, predictive decision support, robust and trustworthy learning algorithms, and scalable inference on edge or autonomous systems.

We are especially interested in collaborating where AI/ML can provide the core reasoning, prediction, or safety-critical analytics component within a larger robotic, sensing, or clinical platform. TA1: Endovascular Robotics, TA2: Microbots Luke Beardslee University of Maryland labeardslee04@gmail.

com Maryland USA, MD Ingestible, wearable and implantable sensors and actuators Integrated Circuits Expertise, Animal Testing Expertise, Wireless Energy Transfer TA2: Microbots, TA1: Endovascular Robotics Rani Elhajjar University of Wisconsin-Milwaukee elhajjar@uwm. edu Milwaukee, WI Our team excels in smart materials and composites, with expertise in magnetostrictive composties, PVDF and fiber optic strain sensors.

For TA1, we enable real-time force feedback for safer navigation. For TA2, we support miniaturized, sensor-integrated microbots for precise actuation. We seek collaborators to advance autonomous medical interventions.

Embedded sensing, material-response modeling, and experimental validation TA1: Endovascular Robotics, TA2: Microbots Jacob Biehl University of Pittsburgh jacobbiehl@pitt.

edu Pittsburgh, PA Our research focuses on autonomous endovascular robotics through reinforcement learning for catheter/guidewire control, real-time extraction of tool configuration, and live registration between pre-operative anatomy and intraoperative imaging to support navigation. We also study human-factors challenges in spatial perception and interface design to inform safe, fully autonomous thrombectomy and embolization workflows.

We are looking for partners with strong capabilities in robotic hardware, clinical translation, and regulatory strategy. Our team has built custom instruments and sensing platforms for evaluating our methods, but would benefit from collaboration with groups more experienced in scalable device engineering, verification/validation, and clinical deployment.

TA1: Endovascular Robotics Giovanni Pittiglio Worcester Polytechnic Institute gpittiglio@wpi. edu Worcester, MA Our autonomous robot uses contact-aware planning and control to maintain stable, precise tool interaction in dynamic environments. By predicting contact forces and adapting motion in real time, it ensures consistent performance even under uncertainty.

This enables safer, more reliable manipulation for demanding tasks where accuracy and stability are critical. We seek teaming partners with strengths in medical image registration, multimodal image fusion, and advanced image analysis.

Ideal collaborators bring expertise in deformable registration, MRI/CT angiographic processing, and quantitative anatomical mapping, as well as experience building scalable pipelines, validating algorithms on clinical datasets, and translating imaging tools into interventional workflows. TA1: Endovascular Robotics Pallavi Tawde Synap Biotech pallavi. tawde@synapbio.

com San Francisco, CA Synap Biotech is developing a first-in-class Anti-Nogo-A Nanobody® immunotherapy for stroke to counter Nogo-A, the key blocker of neuroplasticity. To overcome the blood brain barrier (BBB) challenge, we plan to use intranasal delivery to bypass the BBB and deliver our Nanobody® therapy directly to the brain.

This proven novel and non-invasive delivery approach is designed to deliver the Nanobody® therapy to its intended target and maximize therapeutic impact. Collaborate and work together with stroke robotics for targeted therapies. TA2: Microbots, TA1: Endovascular Robotics Young-Ho Kim Siemens Healthineers young-ho.

kim@siemens-healthineers. com Princeton, NJ We focus on AI-driven image-to-action automation across X-ray/fluoro, ultrasound, CT, and MRI. Our work spans multimodal perception, autonomous view navigation, tool/tip tracking, therapy safety guarding, and predictive catheter control under X-ray for motion-aware view planning.

We also advance multi-agent path planning and trajectory optimization. These capabilities underpin our Auto-Copilot framework, enabling end-to-end clinical procedure automation. We seek partners with expertise in micro-scale interventional devices, including magnetically assisted micro-tools or controllable micro-actuators that can operate within vascular or confined anatomical environments.

Ideal collaborators contribute novel device designs or actuation methods for fine-scale manipulation. We aim to combine such innovations with Siemens’ AI-based image-to-action autonomy for next-generation closed-loop interventions. TA2: Microbots, TA2: Microbots Emily Shaw Mentice emily.

shaw@mentice. com 820 W Jackson Blvd, Ste 250 Chicago, IL Mentice Mentice has developed an anatomical software physics engine, combined with haptic-enabled hardware solutions, creates the optimal environment for procedural adoption, proficiency-based training, patient-specific simulation, and objective skills assessment. Over 350 development years of engineering have created the most advanced IGIT simulation solutions on the market.

TA1: Endovascular Robotics, TA1: Endovascular Robotics Madison Clark-Turner Charles River Analytics mclarkturner@cra. com Cambridge, MA Charles River Analytics brings 40 years of software and AI innovation, extensive DARPA, ARPA-H,